Breast cancer patients from WSI had significantly younger age of diagnosis, higher proportion of pre-menopausal patients, higher proportion of high-grade tumours, and higher proportion of ER- and PR-negative, and triple-negative breast cancers compared to that of TCGA (S1 Table). This evidence concerns the gene ESR1 and neoplasm.